Ilya Zubkov
Stock Analyst at Freedom Capital Markets
(3.47)
# 2,351
Out of 4,712 analysts
24
Total ratings
52.9%
Success rate
16.2%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Maintained: Hold | $5 | $7.30 | -31.51% | 2 | Aug 11, 2026 | |
| ILMN Illumina | Downgraded: Hold | $185 | $211.06 | -12.35% | 1 | Aug 5, 2026 | |
| VMD Viemed Healthcare | Downgraded: Hold | $11 | $8.79 | +25.14% | 1 | Aug 5, 2026 | |
| SMTI Sanara MedTech | Downgraded: Hold | $35 | $35.05 | -0.14% | 2 | Aug 3, 2026 | |
| JNJ Johnson & Johnson | Upgraded: Buy | $280 | $269.12 | +4.04% | 1 | Jul 16, 2026 | |
| NAGE Niagen Bioscience | Initiated Coverage: Buy | $9 | $3.10 | +190.32% | 1 | Jul 6, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Initiated Coverage: Buy | $27 | $15.63 | +72.74% | 1 | Jul 2, 2026 | |
| ATYR aTyr Pharma | Upgraded: Buy | $3.5 | $0.4808 | +627.95% | 1 | May 20, 2026 | |
| ATRA Atara Biotherapeutics | Upgraded: Hold | $10 | $10.23 | -2.25% | 1 | May 18, 2026 | |
| AMGN Amgen | Upgraded: Buy | $375 | $393.17 | -4.62% | 1 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $245 | $212.50 | +15.29% | 1 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $5.23 | +129.45% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $15.22 | +5.12% | 1 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $116 | $84.40 | +37.44% | 1 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $4.09 | +389.00% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $2.10 | +185.71% | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $37 | $20.94 | n/a | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $4.98 | n/a | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $12.60 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $27.51 | n/a | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $3.09 | n/a | 1 | Mar 18, 2025 |
Sionna Therapeutics
Aug 11, 2026
Maintained: Hold
Price Target: $5
Current: $7.30
Upside: -31.51%
Illumina
Aug 5, 2026
Downgraded: Hold
Price Target: $185
Current: $211.06
Upside: -12.35%
Viemed Healthcare
Aug 5, 2026
Downgraded: Hold
Price Target: $11
Current: $8.79
Upside: +25.14%
Sanara MedTech
Aug 3, 2026
Downgraded: Hold
Price Target: $35
Current: $35.05
Upside: -0.14%
Johnson & Johnson
Jul 16, 2026
Upgraded: Buy
Price Target: $280
Current: $269.12
Upside: +4.04%
Niagen Bioscience
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $3.10
Upside: +190.32%
Arcturus Therapeutics Holdings
Jul 2, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $15.63
Upside: +72.74%
aTyr Pharma
May 20, 2026
Upgraded: Buy
Price Target: $3.5
Current: $0.4808
Upside: +627.95%
Atara Biotherapeutics
May 18, 2026
Upgraded: Hold
Price Target: $10
Current: $10.23
Upside: -2.25%
Amgen
May 7, 2026
Upgraded: Buy
Price Target: $375
Current: $393.17
Upside: -4.62%
May 1, 2026
Upgraded: Buy
Price Target: $245
Current: $212.50
Upside: +15.29%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $5.23
Upside: +129.45%
Apr 6, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $15.22
Upside: +5.12%
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $116
Current: $84.40
Upside: +37.44%
Mar 30, 2026
Upgraded: Buy
Price Target: $20
Current: $4.09
Upside: +389.00%
Sep 30, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $2.10
Upside: +185.71%
Aug 11, 2025
Upgraded: Buy
Price Target: $14 → $37
Current: $20.94
Upside: n/a
Aug 4, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $4.98
Upside: n/a
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $12.60
Upside: n/a
Jul 1, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $27.51
Upside: n/a
Mar 18, 2025
Maintained: Buy
Price Target: $13
Current: $3.09
Upside: n/a